Sheets Smith Investment Management’s Pfizer PFE Stock Holding History

Sheets Smith Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$204K	Buy	+8,012	New	+$198K	0.13%	127

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sheets Smith Investment Management's PFE Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in Pfizer (PFE) in Q3 2025: 8,012 shares worth $204K. The stake represents 0.13% of the portfolio and ranks #127 among its holdings.

2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

Sheets Smith Investment Management held 8,012 shares of Pfizer worth $204K as of Q3 2025.
Pfizer was a new Sheets Smith Investment Management position in Q3 2025.
Pfizer made up 0.13% of Sheets Smith Investment Management's portfolio in Q3 2025, its #127 holding.
2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.